Literature DB >> 15824358

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.

S H Subramony1, W May, D Lynch, C Gomez, K Fischbeck, M Hallett, P Taylor, R Wilson, T Ashizawa.   

Abstract

Measuring the severity of neurologic dysfunction in patients with inherited ataxias, including Friedreich ataxia (FA), is difficult because of the variable rate of progression, the variable age at onset and the variety of neural systems that may be affected. The authors discuss the problems related to rating scales in the ataxias, report a neurologic rating scale for FA, and demonstrate acceptable interrater reliability of the instrument.

Entities:  

Mesh：

Year:  2005        PMID： 15824358     DOI： 10.1212/01.WNL.0000156802.15466.79

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  105 in total

1.  Longitudinal change in dysarthria associated with Friedreich ataxia: a potential clinical endpoint.

Authors:  Kristin M Rosen; Joanne E Folker; Adam P Vogel; Louise A Corben; Bruce E Murdoch; Martin B Delatycki
Journal:  J Neurol       Date:  2012-06-06       Impact factor: 4.849

2.  A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.

Authors:  Marguerite V Evans-Galea; Louise A Corben; Justin Hasell; Charles A Galea; Michael C Fahey; Desirée du Sart; Martin B Delatycki
Journal:  Neurogenetics       Date:  2011-08-10       Impact factor: 2.660

3.  GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients.

Authors:  Christian Marcotulli; Silvia Fortuni; Gaetano Arcuri; Barbara Tomassini; Luca Leonardi; Francesco Pierelli; Roberto Testi; Carlo Casali
Journal:  Neurol Sci       Date:  2015-11-30       Impact factor: 3.307

Review 4.  Emerging therapies in Friedreich's ataxia.

Authors:  Tanya V Aranca; Tracy M Jones; Jessica D Shaw; Joseph S Staffetti; Tetsuo Ashizawa; Sheng-Han Kuo; Brent L Fogel; George R Wilmot; Susan L Perlman; Chiadi U Onyike; Sarah H Ying; Theresa A Zesiewicz
Journal:  Neurodegener Dis Manag       Date:  2016

5.  Structural cerebellar correlates of cognitive and motor dysfunctions in cerebellar degeneration.

Authors:  Kalyani Kansal; Zhen Yang; Ann M Fishman; Haris I Sair; Sarah H Ying; Bruno M Jedynak; Jerry L Prince; Chiadi U Onyike
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

Review 6.  An update on inherited ataxias.

Authors:  Tanja Schmitz-Hübsch; Thomas Klockgether
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

7.  Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument.

Authors:  H Jacobi; M Rakowicz; R Rola; R Fancellu; C Mariotti; P Charles; A Dürr; M Küper; D Timmann; C Linnemann; L Schöls; O Kaut; C Schaub; A Filla; L Baliko; B Melegh; J-S Kang; P Giunti; B P C van de Warrenburg; R Fimmers; T Klockgether
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

8.  Neuroanatomical correlates of depression in Friedreich's ataxia: a voxel-based morphometry study.

Authors:  Cynthia B da Silva; Clarissa L Yasuda; Anelyssa D'Abreu; Fernando Cendes; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

9.  Cerebral and cerebellar grey matter atrophy in Friedreich ataxia: the IMAGE-FRDA study.

Authors:  Louisa P Selvadurai; Ian H Harding; Louise A Corben; Monique R Stagnitti; Elsdon Storey; Gary F Egan; Martin B Delatycki; Nellie Georgiou-Karistianis
Journal:  J Neurol       Date:  2016-08-13       Impact factor: 4.849

10.  Impairment in motor reprogramming in Friedreich ataxia reflecting possible cerebellar dysfunction.

Authors:  Louise A Corben; Martin B Delatycki; John L Bradshaw; Malcolm K Horne; Michael C Fahey; Andrew J Churchyard; Nellie Georgiou-Karistianis
Journal:  J Neurol       Date:  2009-12-03       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.